Turkey / Pharma Industry Data Snapshot 2021
According to a recent report by IEIS, Turkey’s Pharmaceutical Manufacturers Association, there are approximately…
Top Stories
Download / InFocus Precision Medicine in Asia 2021
Asia is at the forefront of new trends in precision medicine, from pioneering work in molecular diagnostics to increasingly tailored solutions in the war against cancer and in-depth genomic data…
MEA / In Conversation with Amgen's Mohamed Nasser
Amgen’s Middle East and Africa General Manager Mohamed Nasser discusses the company’s approach to the region;…
Egypt / Trade Deficit Plummets; Big UAE Investments; Vaccine Manufacturing Developments
As of today, the Evergreen boat that blocked global shipping when it got stuck in the Suez Canal has still not been…
USA / Impact of COVID-19 on US Clinical Studies Conducted by Japan-Based Pharmaceutical Companies
Writing in the June edition of DIA’s Global Forum magazine, representatives of Japanese pharmaceutical companies…
China / A New Era of Reform Transforming Regulatory Professionals
Writing in the June edition of DIA’s Global Forum magazine, Harbour BioMed’s Fang Zhou, in conversation…
Switzerland / Tillotts CEO Talks SME M&A Principles
Thomas A. Tóth von Kiskér, longstanding CEO of Tillotts Pharma AG, a specialty pharma player focused on the…
In Conversation
Alejandro Paolini – Managing Director Mexico, Central America & Caribbean, Siemens Healthineers
Alejandro Paolini, Siemens Healthineers’ managing director for Mexico, Central America and Caribbean, dives into the medical technology industry’s business model transformation, switching from selling products to services with a risk-sharing approach. In addition, he reflects on the impact of the pandemic on the company’s performance, their unique presence in Central America and the ways in which Siemens Healthineers can help…
Latest Reports
Focus on Europe
Danish Life Sciences: A Force to Be Reckoned With
On April 16, the Danish government unveiled, to great anticipation and fanfare,…
Spanish Pharma News: Market Growth; Esteve’s US Expansion;…
The latest from Spanish pharma, including the acquisition of PTS by a private…
Switzerland Biotech Listing Snapshot 2021
The SXI Bio & MedTech Index outperformed the Swiss Performance Index (SPI)…
Vaccine Wars: What the EU/AstraZeneca Row Shows Us About…
Stuart Evans, partner at law firm BLM and specialist in commercial disputes and…
Read more: Europe >>
Focus on Singapore
The Challenges of Regulatory Convergence in APAC Medtech
Regulatory harmonisation for medical devices between countries in Asia-Pacific…
APAC: How Precision Medicine is Transforming the Oncology…
Asia-Pacific, as home to 50 percent of the world’s new cancer cases each year…
Varian’s Kenneth Tan on the Future of Cancer Care in…
Kenneth Tan has been President for Asia Pacific & Japan at cancer-focused…
Singapore: Finding the Right Pharma Talent Post-COVID
Singapore – despite its modest USD 1.22 billion domestic market – has long…
Read more: Singapore >>
Focus on Turkey
Turkey Pharma Industry Data Snapshot 2021
According to a recent report by IEIS, Turkey’s Pharmaceutical Manufacturers…
MEA: Iran looks to Cuba for COVID-19 Vaccine; Israel Leads…
The latest COVID-19 vaccine news from the Middle East & Africa (MEA) region,…
Top Turkish Biopharma Companies 2020
As Turkey's pharmaceutical industry makes its first steps away from competitive…
Turkey’s Moment of Reckoning on Diabetes?
As COVID-19 began spreading through the world, the race to understand the…
Read more: Turkey >>
Focus on China
Roche Hoping to Spearhead ‘Created in China’ Push with…
In May 2021 Swiss giant Roche launched the ‘Roche Accelerator’ in Shanghai,…
China’s New Era of Reform Transforming Regulatory…
Writing in the June edition of DIA's Global Forum magazine, Harbour BioMed's…
APAC: Generic Penetration by Country
Generics penetration in the Asia-Pacific region by country for 2018. A full 90.3…
China Pharma News: BioNTech-Fosun JV; Patent Law Revamp;…
The latest news from Chinese pharma, including an overhaul of the country’s…
Read more: China >>
Focus on Switzerland
Switzerland’s Upcoming Cost Containment Packages:…
While once considered the land of milk and honey within Europe in terms of…
Switzerland’s Quest for Alternatives to Animal Testing of…
Animal testing for medicinal purposes is back under the spotlight in Switzerland…
What Switzerland Means to Novartis & Roche
The Novartis and Roche names are synonymous with Swiss pharmaceutical…
Lonza Goes Big with Swiss Investments in Biologics, ADCs…
In the last month alone, CDMO giant Lonza has announced three major upgrades to…
Read more: Switzerland >>
Focus on Vaccines
IP PACT: A Journey, Not a Destination
The issue of COVID-19 vaccine access in developing nations has thrust…
Sputnik V: A Brief History of Russia’s Controversial Viral…
Although Russian authorities received heavy criticism for approving the Sputnik…
Southeast Asia: Kalbe Underwhelms in Indonesia; Novavax…
The latest from the pharma industry in Southeast Asia, including underwhelming…
Industry Warns of Vaccine Manufacturing Bottlenecks;…
Big Pharma’s representatives are warning of upcoming bottlenecks in the…
Read more: Vaccines >>
Focus on USA
Moderna: Bullish Bancel “Not Losing Sleep” over COVID-19…
The day the Biden administration announced its support for the waiver of IP…
US Generics & Biosimilars: Five Takeaways from Access!…
Dan Leonard of the Association for Accessible Medicines (AAM) highlights five…
If the “Primary Endpoint” in an…
Taking the example of music's effect on Alzheimer's disease patients, John G…
Impact of COVID-19 on US Clinical Studies Conducted by…
Writing in the June edition of DIA’s Global Forum magazine, representatives of…
Read more: USA >>
Focus on Saudi Arabia
Saudization: Local Staffing Obligations & Big…
Historically dependent on oil, Saudi Arabia, like most countries in the Arabian…
MENA Pharma News: Egypt Opens ‘Pharma City’;…
The latest Middle East and North Africa (MENA) pharma, including Egypt’s…
Saudi Arabia: SFDA CEO Sets Out Strategic Priorities
In a recent conversation with PharmaBoardroom, Prof. Hisham Bin Saad Al-Jadhey,…
MEA: Pfizer’s Saudi Transformation; Urgent Call for Arab…
The latest news from Middle East & North African pharma, including…